InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by McGrath Lynne Fahey, Director. Insider active across 1 company, notably Alzamend Neuro, Inc.. Aggregated, 7 disclosures have been logged. Breakdown: 1 buy · 3 sells. Total volume traded: €59k. Activity tracked since 13 September 2021. The latest transaction was filed on 23 October 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to McGrath Lynne Fahey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
30 shares@ US$2.290.1% of flowCommon StockSEC:0001214659-25-015288:0
10,000 shares@ US$0.4356.8% of flowCommon StockSEC:0001214659-23-004146:0
Canonical exit: 20 Jun 2023 (T+90)
25,000 shares@ US$1.2130.46% mcap50.0% of flowCommon StockSEC:0001214659-22-004992:0
25,000 shares@ US$1.21387.1% of flowCommon StockSEC:0001214659-22-004914:0
50,000 shares0Common StockSEC:0001214659-22-003986:0
47,222 shares0Common StockSEC:0001214659-21-010561:0
2,778 shares0Common StockSEC:0001214659-21-009540:0
7 of 7 declarations
About McGrath Lynne Fahey
McGrath Lynne Fahey is Administrateur at Alzamend Neuro, Inc. (XNAS). There are 7 filings in total, and across the 7 sampled recent filings, the amounts are EUR 4037 in purchases and EUR 55226 in sales, over the period from 2021-09-15 to 2025-10-24. The modal transaction nature is Cession.
